Free Newsletter
Plant-based norovirus vax ready for human tests
Every winter, norovirus--more commonly called the vomiting virus--causes misery on board cruise ships and inside schools and other places where people often crowd together. Now a group of scientists say that they're preparing to start human tests on a new vaccine for the virus that was manufactured using tobacco plants.
Using an engineered version of the plant, researchers at Arizona State University say that they can whip up a vaccine for tests inside of 10 weeks, with commercial scale production up and running in a matter of months. That kind of ready, aim, fire approach would be necessary to counter any outbreaks, as the norovirus is notoriously unstable and subject to frequent mutations.
In an animal study, the scientists say that the engineered plant virus--which doesn't include infectious material--spurred an effective immune response. They also developed a nasal delivery system which will be put to the test later this year.
- read the report from the BBC
Comments
Post new comment
Paid Research Reports
- Pricing and Reimbursement: Innovative Risk-Sharing Strategies
- Emerging Markets Series: The Pharmaceutical Market of Poland
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D;: Evolving strategies to rejuvenate R&D; efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations




Click here to get the FierceVaccines email newsletter for FREE!
Be the first to comment